Details for New Drug Application (NDA): 065110
✉ Email this page to a colleague
The generic ingredient in CYCLOSPORINE is cyclosporine. There are eighteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
Summary for 065110
Tradename: | CYCLOSPORINE |
Applicant: | Ivax Sub Teva Pharms |
Ingredient: | cyclosporine |
Patents: | 0 |
Pharmacology for NDA: 065110
Mechanism of Action | Calcineurin Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors |
Medical Subject Heading (MeSH) Categories for 065110
Suppliers and Packaging for NDA: 065110
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CYCLOSPORINE | cyclosporine | CAPSULE;ORAL | 065110 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-9018 | 0093-9018-65 | 30 BLISTER PACK in 1 CARTON (0093-9018-65) / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0093-9018-19) |
CYCLOSPORINE | cyclosporine | CAPSULE;ORAL | 065110 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-9019 | 0093-9019-65 | 30 BLISTER PACK in 1 CARTON (0093-9019-65) / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0093-9019-19) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Mar 29, 2005 | TE: | AB1 | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Mar 29, 2005 | TE: | AB1 | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
Approval Date: | Mar 29, 2005 | TE: | AB1 | RLD: | No |
Complete Access Available with Subscription